• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情第二波期间 COVID-19 患者的临床表现和社会人口学特征:孟加拉国的经验。

Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.

机构信息

Professor Joarder DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh; The First Affiliated Hospital, School of Life Sciences and Medical Center, University of Science and Technology of China (USTC), Hefei, Anhui 230027, China.

Professor Joarder DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh.

出版信息

J Infect Public Health. 2021 Oct;14(10):1367-1374. doi: 10.1016/j.jiph.2021.06.011. Epub 2021 Jun 25.

DOI:10.1016/j.jiph.2021.06.011
PMID:34215560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8233048/
Abstract

BACKGROUND

Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh.

METHODS

A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR undergoing a specialized COVID-19 hospital. From March 1 to April 15, 2021, a total of 1326 samples were collected. Samples were only obtained from non-critical COVID-19 patients as critically ill patients required emergency intensive care medications. Then, from April 17 to May 03, 2021, SARS-CoV-2 infection and clinical assessment was performed based on interim guidelines from the WHO. The diagnosis was conducted through RT-PCR. Later, identifying the symptomatic and asymptomatic patient based on checking the Clinical Observation Form (COF). The patients filled the COF form. Finally, statistical analyses were done using the SPSS 20 statistical program.

RESULTS

In this investigation, a total of 326 patients were diagnosed as COVID-19 positive. Among them, approximately 19.02% (n = 62) were asymptomatic, and 80.98% (n = 264) were symptomatic. Here, the finding shows that the occurrence of this infection was varied depending on age, sex, residence, occupation, smoking habit, comorbidities, etc. However, Males (60.12%) were more affected than females (39.88%), and, surprisingly, this pandemic infected both urban and rural residents almost equally (urban = 50.92%; rural = 49.08%). Approximately 19% of the asymptomatic and 62% of symptomatic cases had at least one comorbid disorder. Interestingly, an unexpected result was exhibited in the case of smokers, where non-smokers were more affected than smokers. The study indicates community transmission of COVID 19, where people were highly infected at their occupations (35.58%), at houses (23.93%) and by traveling (12.88%). Noteworthy, according to this report, a large number (19.33%) of individuals did not know exactly how they were contaminated with SARS-CoV-2. Patients were most commonly treated by an antibiotic 95.09%, followed in second by corticosteroid 46.01%. Anti-viral drugs, remdesivir, and oxygenation are also needed for other patients. Among those, who were being treated, approximately 69.33% were isolated at home, 27.91% were being treated at dedicated COVID-19 hospitals. Finally, 96.63% were discharged without complications, and 0.03% has died.

CONCLUSION

This investigation concludes that males became more infected than females. Interestingly, both urban and rural people became nearly equally infected. It noticed community transmission of SARS-CoV-2, where people were highly infected at their workplaces. A higher rate of silent transmission indicates that more caution is needed to identify asymptomatic patients. Most of the infected people were isolated at home whereas nearly one-fourth were treated at hospitals. Clinically, antibiotics were the most widely used treatment. However, the majority of the patients were discharged without complications. The current investigation would be helpful to understand the clinical manifestations and socio-demographic situations during the second wave of the COVID-19 pandemic in Bangladesh.

摘要

背景

孟加拉国是一个人口稠密的国家,医疗体系不完善,经济框架也不佳。由于到目前为止,仍有大量民众对此一无所知,因此 COVID-19 第二波感染的发展已成为一个严重的威胁。本研究旨在描述孟加拉国 COVID-19 的临床和社会人口学特征。

方法

对在专门的 COVID-19 医院进行 RT-PCR 检测确诊的所有其他 COVID-19 患者进行横断面分析。2021 年 3 月 1 日至 4 月 15 日期间,共采集了 1326 个样本。由于危重症患者需要紧急重症监护药物,因此仅从非危重症 COVID-19 患者中获取样本。然后,从 2021 年 4 月 17 日至 5 月 3 日,根据世界卫生组织的临时指南,对 SARS-CoV-2 感染和临床评估进行了检测。通过 RT-PCR 进行诊断。随后,根据检查临床观察表(COF)来识别有症状和无症状患者。患者填写 COF 表。最后,使用 SPSS 20 统计程序进行统计分析。

结果

在这项研究中,共有 326 名患者被诊断为 COVID-19 阳性。其中,约 19.02%(n=62)为无症状,80.98%(n=264)为有症状。这里的发现表明,这种感染的发生因年龄、性别、居住地点、职业、吸烟习惯、合并症等因素而异。然而,男性(60.12%)的感染率高于女性(39.88%),令人惊讶的是,这场大流行几乎平等地感染了城市和农村居民(城市=50.92%;农村=49.08%)。约 19%的无症状和 62%的有症状病例至少有一种合并症。有趣的是,在吸烟者的病例中出现了意外的结果,不吸烟者比吸烟者受影响更大。研究表明 COVID-19 存在社区传播,人们在工作场所(35.58%)、家中(23.93%)和旅行中(12.88%)受到高度感染。值得注意的是,根据这份报告,大量(19.33%)的人不知道他们是如何感染 SARS-CoV-2 的。患者最常用的治疗方法是抗生素(95.09%),其次是皮质类固醇(46.01%)。其他患者还需要使用抗病毒药物瑞德西韦和吸氧。在接受治疗的患者中,约 69.33%在家中隔离,27.91%在专门的 COVID-19 医院接受治疗。最后,96.63%的患者无并发症出院,0.03%的患者死亡。

结论

本研究表明,男性比女性更容易感染。有趣的是,城市和农村居民的感染率几乎相同。注意到 SARS-CoV-2 的社区传播,人们在工作场所受到高度感染。较高的沉默传播率表明需要更加小心地识别无症状患者。大多数受感染者在家中隔离,而近四分之一的患者在医院接受治疗。临床上,抗生素是最广泛使用的治疗方法。然而,大多数患者没有并发症出院。本研究将有助于了解孟加拉国 COVID-19 第二波大流行期间的临床症状和社会人口学情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7003/8233048/e43a0887b845/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7003/8233048/cb117835244a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7003/8233048/e43a0887b845/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7003/8233048/cb117835244a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7003/8233048/e43a0887b845/gr2_lrg.jpg

相似文献

1
Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.新冠疫情第二波期间 COVID-19 患者的临床表现和社会人口学特征:孟加拉国的经验。
J Infect Public Health. 2021 Oct;14(10):1367-1374. doi: 10.1016/j.jiph.2021.06.011. Epub 2021 Jun 25.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.斋浦尔市522例COVID-19住院患者的羟氯喹特性、治疗结果及作用:一项流行病学临床研究
J Assoc Physicians India. 2020 Jun;68(6):13-19.
5
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
6
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
7
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
8
Clinical Profile and Short-Term Outcome of SARS-CoV-2-Infected Neonates from a Government Medical College in West Bengal, India.印度西孟加拉邦一所政府医学院的感染 SARS-CoV-2 的新生儿的临床特征和短期结局。
J Trop Pediatr. 2022 Jan 7;68(1). doi: 10.1093/tropej/fmac002.
9
Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.哥伦比亚加勒比地区一组有症状和无症状 SARS-CoV-2 个体的流行病学和病毒特征。
Ann Clin Microbiol Antimicrob. 2020 Dec 7;19(1):58. doi: 10.1186/s12941-020-00397-5.
10
Clinical-Epidemiological Characteristics of the First Patients Diagnosed with COVID-19 in Cuba.古巴首批确诊新冠肺炎患者的临床流行病学特征
MEDICC Rev. 2021 Apr;23(2):15. doi: 10.37757/MR2021.V23.N2.3. Epub 2021 Apr 30.

引用本文的文献

1
Comprehensive Analysis of SARS-CoV-2 Dynamics in Bangladesh: Infection Trends and Variants (2020-2023).孟加拉国 2020-2023 年 SARS-CoV-2 动力学的综合分析:感染趋势和变异体
Viruses. 2024 Aug 7;16(8):1263. doi: 10.3390/v16081263.
2
Clinico-epidemiological profile of non-survivors of COVID-19 during the last two waves in a tertiary care hospital of North India: A retrospective descriptive study.印度北部一家三级护理医院过去两波新冠疫情期间新冠病毒病死亡患者的临床流行病学概况:一项回顾性描述性研究
J Family Med Prim Care. 2023 Oct;12(10):2385-2391. doi: 10.4103/jfmpc.jfmpc_307_23. Epub 2023 Oct 11.
3
A Statistical Synopsis of COVID-19 Components and Descriptive Analysis of Their Socio-Economic and Healthcare Aspects in Bangladesh Perspective.

本文引用的文献

1
Clinico-epidemiological Characteristics of Asymptomatic and Symptomatic COVID-19-Positive Patients in Bangladesh.孟加拉国无症状和有症状 COVID-19 阳性患者的临床流行病学特征。
Mymensingh Med J. 2023 Jan;32(1):185-192.
2
Urban density and COVID-19: understanding the US experience.城市密度与新冠疫情:解读美国的情况
Ann Reg Sci. 2022 Nov 28:1-32. doi: 10.1007/s00168-022-01193-z.
3
COVID-19: Lessons for an Urban(izing) World.新冠疫情:城市化世界的教训
孟加拉国视角下的 COVID-19 组成部分的统计概要和社会经济及医疗保健方面的描述性分析。
J Environ Public Health. 2023 Feb 13;2023:9738094. doi: 10.1155/2023/9738094. eCollection 2023.
4
COVID-19 and monkeypox co-infection: A rapid systematic review.COVID-19 与猴痘合并感染:快速系统评价。
Front Immunol. 2022 Dec 14;13:1094346. doi: 10.3389/fimmu.2022.1094346. eCollection 2022.
5
Post-COVID-19 complications in home and hospital-based care: A study from Dhaka city, Bangladesh.孟加拉国达卡市居家与医院护理中新冠病毒病后的并发症:一项研究
Front Rehabil Sci. 2022 Nov 24;3:1037649. doi: 10.3389/fresc.2022.1037649. eCollection 2022.
6
Transmission Dynamics and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in Bangladesh.孟加拉国新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的传播动力学与基因组流行病学
Trop Med Infect Dis. 2022 Aug 20;7(8):197. doi: 10.3390/tropicalmed7080197.
7
Prevalence of COVID-19 in Bangladesh, April to October 2020-a cross-sectional study.2020年4月至10月孟加拉国新冠肺炎的患病率——一项横断面研究。
IJID Reg. 2021 Dec;1:92-99. doi: 10.1016/j.ijregi.2021.10.003. Epub 2021 Oct 14.
8
Clinicodemographic profile, intensive care unit utilization and mortality rate among COVID-19 patients admitted during the second wave in Bangladesh.孟加拉国第二波疫情期间收治的新冠肺炎患者的临床人口统计学特征、重症监护病房使用情况及死亡率
IJID Reg. 2022 Mar;2:55-59. doi: 10.1016/j.ijregi.2021.11.011. Epub 2021 Dec 3.
9
Clinical profile and short-term outcomes of RT-PCR- positive patients with COVID-19: a cross-sectional study in a tertiary care hospital in Dhaka, Bangladesh.孟加拉国达卡一家三级护理医院的 COVID-19 患者 RT-PCR 阳性的临床特征和短期结局:一项横断面研究。
BMJ Open. 2021 Dec 15;11(12):e055126. doi: 10.1136/bmjopen-2021-055126.
10
Prevalence of comorbid tuberculosis amongst COVID-19 patients: A rapid review and meta-analysis.COVID-19患者中合并肺结核的患病率:快速回顾与荟萃分析
Int J Clin Pract. 2021 Nov;75(11):e14867. doi: 10.1111/ijcp.14867.
One Earth. 2020 Apr 24;2(4):317-319. doi: 10.1016/j.oneear.2020.04.004. Epub 2020 Apr 15.
4
Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19.直击问题核心:新型冠状病毒肺炎的心肌损伤、凝血功能障碍及其他潜在心血管影响
Int J Vasc Med. 2021 Apr 22;2021:6693895. doi: 10.1155/2021/6693895. eCollection 2021.
5
SARS-CoV-2 molecular identification and clinical data analysis of associated risk factors from a COVID-19 testing laboratory of a coastal region in Bangladesh.孟加拉国沿海地区一家新冠病毒检测实验室对SARS-CoV-2的分子鉴定及相关危险因素的临床数据分析
Heliyon. 2021 Apr;7(4):e06650. doi: 10.1016/j.heliyon.2021.e06650. Epub 2021 Mar 29.
6
Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.新型冠状病毒肺炎患者的神经后遗症:病理组织学观察。
Int J Environ Res Public Health. 2021 Feb 3;18(4):1415. doi: 10.3390/ijerph18041415.
7
Histopathology features of the lung in COVID-19 patients.COVID-19患者肺部的组织病理学特征。
Diagn Histopathol (Oxf). 2021 Mar;27(3):123-127. doi: 10.1016/j.mpdhp.2020.11.009. Epub 2020 Dec 4.
8
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.吸烟和尼古丁在 COVID-19 传播和发病机制中的作用。
J Pharmacol Exp Ther. 2020 Dec;375(3):498-509. doi: 10.1124/jpet.120.000170. Epub 2020 Oct 8.
9
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.SARS-CoV-2 病理生理学及其临床意义:COVID-19 药物治疗管理的综合概述。
Food Chem Toxicol. 2020 Dec;146:111769. doi: 10.1016/j.fct.2020.111769. Epub 2020 Sep 30.
10
COVID-19: Brief check through the pathologist's eye (autopsy archive).COVID-19:病理学家视角下的简要检查(尸检档案)。
Pathol Res Pract. 2020 Nov;216(11):153195. doi: 10.1016/j.prp.2020.153195. Epub 2020 Aug 28.